Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vivos Therapeutics (VVOS) Preferred Dividend Payments (2020)

Vivos Therapeutics' Preferred Dividend Payments history spans 1 years, with the latest figure at $1.6 million for Q4 2020.

  • Quarterly results put Preferred Dividend Payments at $1.6 million for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $2.3 million (changed N/A YoY), and the annual figure for FY2020 was $2.3 million, up 133.3%.
  • Preferred Dividend Payments for Q4 2020 was $1.6 million at Vivos Therapeutics, up from $250000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $1.6 million in Q4 2020 to a low of $250000.0 in Q1 2020.